Contact

It's the GeneMedi's summary page for Target/Biomarker Introduction of TNFRSF17. The page also collects GeneMedi's different modalities and formats products for TNFRSF17 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi's target-insight database-GM ITD database, the TNFRSF17 target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Transmembrane Protein.

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation. [provided by RefSeq, Jul 2008]

Target IDGM-T66693
Target NameTNFRSF17
Gene ID608
Gene Official NameTNFRSF17
Gene AliasBCM, BCMA, CD269, TNFRSF13A
Protein Sub-locationTransmembrane Protein
CategoryTherapeutics Target, INN Index, Cytokine Target, Immuno-oncology Target


Pre-made TNFRSF17-specific INN-index biosimilar (antibody&conjugates)-motacabtagene lurevgedleucel, belantamab mafodotin, idecabtagene vicleucel, Elranatamab, Pavurutamab, Belantamab, Pacanalotamab, ciltacabtagene autoleucel, Alnuctamab, zevorcabtagene autoleucel, Teclistamab, orvacabtagene autoleucel

Anti-TNFRSF17 therapeutic INN-index antibodies and conjugates are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody for drug discovery, target MOA research, cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Cat No.Products Name (INN Index)INN Name Previous Name Target FormatOrder
GMP-Bios-INN-919motacabtagene lurevgedleucelTNFRSF17Engineering T cellINN mab
GMP-Bios-INN-752Pre-Made Belantamab Mafodotin Biosimilar, Whole Mab Adc, Anti-Tnfrsf17 Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A therapeutic antibody Drug Conjugatebelantamab mafodotinTNFRSF17Whole mAb ADCINN mab
GMP-Bios-INN-860idecabtagene vicleucelTNFRSF17Engineering T cellINN mab
GMP-Bios-ab-663Pre-Made Elranatamab biosimilar, Whole mAb, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibodyElranatamabTNFRSF17;CD3EBispecific Whole mAbINN mab
GMP-Bios-ab-433Pre-Made Pavurutamab biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibodyPavurutamabTNFRSF17;CD3EBispecific scFvINN mab
GMP-Bios-ab-055Pre-Made Belantamab biosimilar, Whole mAb ADC, Anti-TNFRSF17 Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A therapeutic antibodyBelantamabTNFRSF17Whole mAb ADCINN mab
GMP-Bios-ab-421Pre-Made Pacanalotamab biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibodyPacanalotamabTNFRSF17;CD3EBispecific scFvINN mab
GMP-Bios-INN-779ciltacabtagene autoleucelTNFRSF17Engineering T cellINN mab
GMP-Bios-ab-018Pre-Made Alnuctamab biosimilar, Bispecific mAb with Domain Crossover, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibodyAlnuctamabTNFRSF17;CD3EBispecific mAb with Domain CrossoverINN mab
GMP-Bios-INN-1056zevorcabtagene autoleucelTNFRSF17Engineering T cellINN mab
GMP-Bios-ab-557Pre-Made Teclistamab biosimilar, Bispecific mAb, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibodyTeclistamabTNFRSF17;CD3EBispecific mAbINN mab
GMP-Bios-INN-942orvacabtagene autoleucelTNFRSF17Engineering T cellINN mab



Pre-made anti-TNFRSF17 inhibitory monoclonal antibody(mab, blocking antibody inhibitor)-benchmark reference antibody for drug discovery and mechanism of action (MOA) research

Pre-made anti-TNFRSF17 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TNFRSF17 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Cat No.Antibody NameFormatClassified by tagOrder
GM-Tg-hg-T66693-AbAnti-TNFRSF17 monoclonal antibodymabBiofunctional antibody, Therapeutics Target antibody, Cytokine antibodymonoclonal antibody.




GENEMEDI
6th Floor, Building No.2, Kangxin Road 3377, Shanghai, China
Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
Chinese Website

Apply for
Free
Sample

Sample FOC application

×